health ๐ฉบ Diabetes meds might lower TB risk
A new international study suggests that GLP-1 medications could reduce tuberculosis risk in people with type 2 diabetes. Researchers analyzed data from 143 healthcare organizations between 2017 and 2025, comparing GLP-1RAs against other common diabetes treatments. The use of GLP-1RAs showed a 51% lower TB risk compared to DPP-4 inhibitors, and a 47% lower risk versus sulfonylureas. This suggests GLP-1RAs might offer protection beyond just managing blood sugar and weight. Further prospective studies are needed to confirm this potential protective mechanism. ๐ฉบ